Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Agarwala SS, Glaspy J, O'Day SJ, Mitchell M, Gutheil J, Whitman E, Gonzalez R, Hersh E, Feun L, Belt R, Meyskens F, Hellstrand K, Wood D, Kirkwood JM, Gehlsen KR, Naredi P. Agarwala SS, et al. Among authors: hellstrand k. J Clin Oncol. 2002 Jan 1;20(1):125-33. doi: 10.1200/JCO.2002.20.1.125. J Clin Oncol. 2002. PMID: 11773161 Clinical Trial.
Histamine in immunotherapy of advanced melanoma: a pilot study.
Hellstrand K, Naredi P, Lindner P, Lundholm K, Rudenstam CM, Hermodsson S, Asztély M, Hafström L. Hellstrand K, et al. Cancer Immunol Immunother. 1994 Dec;39(6):416-9. doi: 10.1007/BF01534430. Cancer Immunol Immunother. 1994. PMID: 8001030 Free PMC article.
Histamine, cimetidine and colorectal cancer.
Hellstrand K, Brune M, Mellqvist UH, Naredi P. Hellstrand K, et al. Nat Med. 1996 Apr;2(4):364-5. doi: 10.1038/nm0496-364a. Nat Med. 1996. PMID: 8597928 No abstract available.
Histamine in cancer immunotherapy.
Hellstrand K, Hermodsson S, Brune M, Naredi P, Carneskog J, Mellqvist UH. Hellstrand K, et al. Scand J Clin Lab Invest. 1997 May;57(3):193-202. doi: 10.3109/00365519709060027. Scand J Clin Lab Invest. 1997. PMID: 9238754 Review.
Histamine and cytokine therapy.
Hellstrand K, Hermodsson S, Naredi P, Mellqvist UH, Brune M. Hellstrand K, et al. Acta Oncol. 1998;37(4):347-53. doi: 10.1080/028418698430566. Acta Oncol. 1998. PMID: 9743456 Review.
Histamine: a novel approach to cancer immunotherapy.
Hellstrand K, Brune M, Naredi P, Mellqvist UH, Hansson M, Gehlsen KR, Hermodsson S. Hellstrand K, et al. Cancer Invest. 2000;18(4):347-55. doi: 10.3109/07357900009012178. Cancer Invest. 2000. PMID: 10808371 Review.
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study.
Donskov F, von der Maase H, Henriksson R, Stiemer U, Wersäll P, Nellemann H, Hellstrand K, Engman K, Naredi P. Donskov F, et al. Among authors: hellstrand k. Ann Oncol. 2002 Mar;13(3):441-9. doi: 10.1093/annonc/mdf049. Ann Oncol. 2002. PMID: 11996477 Free article. Clinical Trial.
201 results